FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2133063026> ?p ?o ?g. }

• W2133063026 endingPage "658" @default.
• W2133063026 startingPage "651" @default.
• W2133063026 abstract "Low-dose combination therapy has been proposed as a rational first-line approach to hypertension treatment. We compared the efficacy and tolerability of the fixed combination of reserpine (0.1 mg) plus the thiazide clopamid (5 mg) with its single components and the calcium-antagonist nitrendipine (20 mg) in a randomized, double-blind, parallel study of 273 hypertensive patients with diastolic blood pressure (BP) between 100 and 114 mm Hg. The four groups did not differ regarding baseline characteristics (mean age, 58 years; 51% men; mean BP after a 2-week placebo period, 158 to 160/103 to 104 mm Hg). After 6 weeks of treatment with one capsule daily, mean reductions in sitting BP from baseline at 24 hours after dosing in the reserpine-clopamid combination, reserpine, clopamid, and nitrendipine groups were −23.0/−17.1, −14.0/−11.7, −13.6/−11.9, and −11.6/−12.3 mm Hg, respectively (2 P <.01). The corresponding normalization rates (diastolic BP <90 mm Hg) were 55%, 40%, 36%, and 33% (2 P =.11). All patients whose BP had not been normalized at this point received two capsules of the respective medication once daily from weeks 7 to 12. At week 12, mean BP reductions were −25.7/−18.1, −14.6/−12.2, −17.7/−13.4, and −14.9/−15.3 mm Hg in the four groups, respectively (2 P <.01). The respective normalization rates were 69%, 35%, 39%, and 45% (2 P <.0001). Linear regression modeling indicated that reserpine and clopamid combined acted more than additively. As regards tolerability, adverse experiences were observed in 27%, 28%, 29%, and 48% of patients, respectively (2 P <.05). The respective rates of premature discontinuation because of adverse effects were 3%, 3%, 7%, and 13% (2 P =.06). In conclusion, a low-dose combination of reserpine and clopamid lowered BP significantly more than both the components alone and nitrendipine. Moreover, the combination was tolerated as well as its components and significantly better than nitrendipine. Thus, the use of this low-dose reserpine-thiazide combination appears to be a rational alternative to conventional monotherapy in the first-line treatment of hypertension." @default.
• W2133063026 created "2016-06-24" @default.
• W2133063026 creator A5026155358 @default.
• W2133063026 creator A5040894205 @default.
• W2133063026 creator A5053155088 @default.
• W2133063026 creator A5065986732 @default.
• W2133063026 creator A5073431279 @default.
• W2133063026 date "1997-02-01" @default.
• W2133063026 modified "2023-09-26" @default.
• W2133063026 title "Different Concepts in First-Line Treatment of Essential Hypertension" @default.
• W2133063026 cites W1982162449 @default.
• W2133063026 cites W1985388908 @default.
• W2133063026 cites W1991678131 @default.
• W2133063026 cites W1992112570 @default.
• W2133063026 cites W1998215428 @default.
• W2133063026 cites W2003441364 @default.
• W2133063026 cites W2020182072 @default.
• W2133063026 cites W2026674070 @default.
• W2133063026 cites W2029809211 @default.
• W2133063026 cites W2030168923 @default.
• W2133063026 cites W2035486914 @default.
• W2133063026 cites W2040112396 @default.
• W2133063026 cites W2056374184 @default.
• W2133063026 cites W2080326452 @default.
• W2133063026 cites W2087724099 @default.
• W2133063026 cites W2099768341 @default.
• W2133063026 cites W2137176186 @default.
• W2133063026 cites W2153899993 @default.
• W2133063026 cites W2312958829 @default.
• W2133063026 cites W2318174853 @default.
• W2133063026 cites W2435772150 @default.
• W2133063026 cites W2552893799 @default.
• W2133063026 cites W4210944093 @default.
• W2133063026 cites W4241356349 @default.
• W2133063026 cites W4242476178 @default.
• W2133063026 cites W4244918166 @default.
• W2133063026 cites W4249101651 @default.
• W2133063026 cites W4251575911 @default.
• W2133063026 cites W4255974390 @default.
• W2133063026 doi "https://doi.org/10.1161/01.hyp.29.2.651" @default.
• W2133063026 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9040452" @default.
• W2133063026 hasPublicationYear "1997" @default.
• W2133063026 type Work @default.
• W2133063026 sameAs 2133063026 @default.
• W2133063026 citedByCount "28" @default.
• W2133063026 countsByYear W21330630262012 @default.
• W2133063026 countsByYear W21330630262013 @default.
• W2133063026 countsByYear W21330630262014 @default.
• W2133063026 countsByYear W21330630262015 @default.
• W2133063026 countsByYear W21330630262016 @default.
• W2133063026 countsByYear W21330630262019 @default.
• W2133063026 countsByYear W21330630262021 @default.
• W2133063026 crossrefType "journal-article" @default.
• W2133063026 hasAuthorship W2133063026A5026155358 @default.
• W2133063026 hasAuthorship W2133063026A5040894205 @default.
• W2133063026 hasAuthorship W2133063026A5053155088 @default.
• W2133063026 hasAuthorship W2133063026A5065986732 @default.
• W2133063026 hasAuthorship W2133063026A5073431279 @default.
• W2133063026 hasConcept C126322002 @default.
• W2133063026 hasConcept C126894567 @default.
• W2133063026 hasConcept C142724271 @default.
• W2133063026 hasConcept C170493617 @default.
• W2133063026 hasConcept C197934379 @default.
• W2133063026 hasConcept C204787440 @default.
• W2133063026 hasConcept C27081682 @default.
• W2133063026 hasConcept C2776885963 @default.
• W2133063026 hasConcept C2777097880 @default.
• W2133063026 hasConcept C2777842393 @default.
• W2133063026 hasConcept C2778375690 @default.
• W2133063026 hasConcept C2780548744 @default.
• W2133063026 hasConcept C57900726 @default.
• W2133063026 hasConcept C71924100 @default.
• W2133063026 hasConcept C84393581 @default.
• W2133063026 hasConceptScore W2133063026C126322002 @default.
• W2133063026 hasConceptScore W2133063026C126894567 @default.
• W2133063026 hasConceptScore W2133063026C142724271 @default.
• W2133063026 hasConceptScore W2133063026C170493617 @default.
• W2133063026 hasConceptScore W2133063026C197934379 @default.
• W2133063026 hasConceptScore W2133063026C204787440 @default.
• W2133063026 hasConceptScore W2133063026C27081682 @default.
• W2133063026 hasConceptScore W2133063026C2776885963 @default.
• W2133063026 hasConceptScore W2133063026C2777097880 @default.
• W2133063026 hasConceptScore W2133063026C2777842393 @default.
• W2133063026 hasConceptScore W2133063026C2778375690 @default.
• W2133063026 hasConceptScore W2133063026C2780548744 @default.
• W2133063026 hasConceptScore W2133063026C57900726 @default.
• W2133063026 hasConceptScore W2133063026C71924100 @default.
• W2133063026 hasConceptScore W2133063026C84393581 @default.
• W2133063026 hasIssue "2" @default.
• W2133063026 hasLocation W21330630261 @default.
• W2133063026 hasLocation W21330630262 @default.
• W2133063026 hasOpenAccess W2133063026 @default.
• W2133063026 hasPrimaryLocation W21330630261 @default.
• W2133063026 hasRelatedWork W1979098222 @default.
• W2133063026 hasRelatedWork W1980988418 @default.
• W2133063026 hasRelatedWork W1984215242 @default.
• W2133063026 hasRelatedWork W2067219190 @default.
• W2133063026 hasRelatedWork W2071699168 @default.

• next